Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome-Reference-Cited by-同舟云学术

Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome

Published:2018-11 Issue:5 Volume:28 Page:737-749.e4
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Natividad Jane M.,Agus Allison,Planchais Julien,Lamas Bruno,Jarry Anne Charlotte,Martin Rebeca,Michel Marie-Laure,Chong-Nguyen Caroline,Roussel Ronan,Straube Marjolene,Jegou Sarah,McQuitty Claire,Le Gall Maude,da Costa Gregory,Lecornet Emmanuelle,Michaudel Chloé,Modoux Morgane,Glodt Jeremy,Bridonneau Chantal,Sovran Bruno,Dupraz Louise,Bado Andre,Richard Mathias L.,Langella Philippe,Hansel Boris,Launay Jean-Marie,Xavier Ramnik J.,Duboc Henri,Sokol Harry

Funder

European Research Council

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference45 articles.

1. Microbiome-modulated metabolites at the interface of host immunity;Blacher;J. Immunol.,2017

2. Metabolic endotoxemia initiates obesity and insulin resistance;Cani;Diabetes,2007

3. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice;Cani;Diabetes,2008

4. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells;Cervantes-Barragan;Science,2017

5. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells;Chimerel;Cell Rep.,2014

Cited by 401 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic nanoplatform with microbiome modulation and antioxidant functions ameliorating insulin resistance and pancreatic β-cell dysfunction for T2DM management;Biomaterials;2025-02

2. Epimedium polysaccharides mitigates Porphyromonas gingivalis-exacerbated intestinal inflammation by suppressing the Th17 pathway and modulating the gut microbiota;International Journal of Biological Macromolecules;2024-10

3. Microbiome 2.0: lessons from the 2024 Gut Microbiota for Health World Summit;Gut Microbes;2024-09-10

4. The influence of AHR on immune and tissue biology;EMBO Molecular Medicine;2024-09-06

5. The effect of microbiome-modulating therapeutics on glucose homeostasis in metabolic syndrome: A systematic review, meta-analysis, and meta-regression of clinical trials;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-09